DFN-98578-45877
3 vaccinations
1 coded response
1 check-in
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 956 / CA
- Registered
- 2022-03-01
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-02-03
Dose 1 — Moderna
-
2021-03-03
Dose 2 — Moderna
-
2022-02-25
Dose 3 — Moderna
-
2022-03-01
Registered in v-safe
-
2022-03-02
Survey response — days 1–6 daily, dose 3MedDRA: Cough, Rhinorrhoea — Feeling: Poor · Headache, Fatigue or tirednessFree text: Runny nose coughMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-03 | Moderna | No |
| 2 | 2021-03-03 | Moderna | No |
| 3 | 2022-02-25 | Moderna | No |
Free text
Release 11 — days 1–6 daily, dose 3
Systemic reaction (other): Runny nose cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Cough | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release